A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour (RESPITE)
Sponsor: Birmingham Women's NHS Foundation Trust
A PHASE4 clinical study on Pain Relief in Labour, this trial is completed. The trial is conducted by Birmingham Women's NHS Foundation Trust and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Nov 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Birmingham Women's NHS Foundation Trust
- Bradford Royal Infirmary
- City Hospital Birmingham
- Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
- Frimley Park Hospital
- Good Hope Hospital
- Heartlands Hospital
- Homerton University Hospital
- Medway Maritime Hospital
- Northwick Park Hospital
- Stoke Mandeville Hospital
- University Hospital Coventry
- University Hospital of North Midlands
- University of Birmingham
- Warwick Hospital
- York Hospital
For direct contact, visit the study record on ClinicalTrials.gov .